Literature DB >> 12581845

The establishment of a reliable cytotoxic system with SK-N-SH neuroblastoma cell culture.

Fang Ba1, Peter K T Pang, Christina G Benishin.   

Abstract

A reliable in vitro cytotoxic system is essential in neurocytotoxic and neuroprotective research. The present study examined four cytotoxic insults with the SK-N-SH human neuroblastoma cell line. These were beta-amyloid protein (Abeta), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), high density culture, and serum deprivation induced neuronal death. These insults induced significant reduction in cell numbers after 96 h culture, in a concentration dependent manner. Among all the insults, MPTP, serum deprivation, and high density culture induced apoptosis after 96 h, while Abeta presumably induced necrotic neuronal death since apoptosis was not detectable. The p38 MAP kinase inhibitor, SB203580 (1 microM), and the PKC inhibitor, chelerythrine (5 microM) successfully inhibited the loss in viability caused by Abeta and the high density culture, respectively. Other kinase inhibitors, including the non-specific protein kinase inhibitor, H7, the PKA inhibitor 14-22 Amide, the PKG inhibitor, KT5823, and the protein tyrosine kinase inhibitor, AG18 had no effect on any of the four cytotoxic models. This system allows the study of neuroprotection under conditions where the different pathways and mechanisms of the neurons can be considered within one cellular system, removing variations which may be due to different cell type studied. The present studies describe an effective model system for screening potential neuroprotective agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12581845     DOI: 10.1016/s0165-0270(02)00324-2

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  12 in total

1.  Evaluation of the importance of astrocytes when screening for acute toxicity in neuronal cell systems.

Authors:  E K Woehrling; E J Hill; M D Coleman
Journal:  Neurotox Res       Date:  2009-07-11       Impact factor: 3.911

2.  Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells.

Authors:  Xiaofei Wang; Evelyn Perez; Ran Liu; Liang-Jun Yan; Robert T Mallet; Shao-Hua Yang
Journal:  Brain Res       Date:  2006-12-15       Impact factor: 3.252

Review 3.  Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil.

Authors:  Moussa B H Youdim; Tamar Amit; Orit Bar-Am; Orly Weinreb; Mara Yogev-Falach
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 4.  Inhibition of protein misfolding and aggregation by natural phenolic compounds.

Authors:  Zohra Dhouafli; Karina Cuanalo-Contreras; El Akrem Hayouni; Charles E Mays; Claudio Soto; Ines Moreno-Gonzalez
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

5.  Expression Profiles of SIRT1 and APP Genes in Human Neuroblastoma SK-N-SH Cells Treated with Two Epigenetic Agents.

Authors:  Yaping Hou; Fanghua Wang; Linping Cheng; Tao Luo; Jie Xu; Huaqiao Wang
Journal:  Neurosci Bull       Date:  2016-08-13       Impact factor: 5.203

6.  Tyrosine kinase inhibitor AG126 reduces 7-ketocholesterol-induced cell death by suppressing mitochondria-mediated apoptotic process.

Authors:  Yun Jeong Kim; Chung Soo Lee
Journal:  Neurochem Res       Date:  2009-12-03       Impact factor: 3.996

7.  p38 MAPK as a negative regulator of VEGF/VEGFR2 signaling pathway in serum deprived human SK-N-SH neuroblastoma cells.

Authors:  Evan Gomes; Patricia Rockwell
Journal:  Neurosci Lett       Date:  2007-12-15       Impact factor: 3.046

Review 8.  Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs.

Authors:  Orly Weinreb; Silvia Mandel; Orit Bar-Am; Merav Yogev-Falach; Yael Avramovich-Tirosh; Tamar Amit; Moussa B H Youdim
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

9.  Retinoic acid inhibits the cytoproliferative response to weak 50‑Hz magnetic fields in neuroblastoma cells.

Authors:  María Ángeles Trillo; María Antonia Martínez; María Antonia Cid; Alejandro Úbeda
Journal:  Oncol Rep       Date:  2012-12-24       Impact factor: 3.906

10.  The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats.

Authors:  Orit Bar-Am; Orly Weinreb; Tamar Amit; Moussa B H Youdim
Journal:  J Mol Neurosci       Date:  2008-08-27       Impact factor: 2.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.